| POHANKA, Michal, Petr KAŇOVSKÝ, Martin BAREŠ, Jiří PULKRÁBEK a Ivan REKTOR. The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial. Online. Parkinsonism and Related Disorders. Oxford: Elsevier, 2005, roč. 11, č. 8, s. 509-512. ISSN 1353-8020. [citováno 2024-04-23] |
Další formáty:
BibTeX
LaTeX
RIS
@article{711902,
author = {Pohanka, Michal and Kaňovský, Petr and Bareš, Martin and Pulkrábek, Jiří and Rektor, Ivan},
article_location = {Oxford},
article_number = {8},
keywords = {Parkinson disease; pergolid; sexual dysfunction},
language = {eng},
issn = {1353-8020},
journal = {Parkinsonism and Related Disorders},
title = {The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial},
volume = {11},
year = {2005}
}
TY - JOUR
ID - 711902
AU - Pohanka, Michal - Kaňovský, Petr - Bareš, Martin - Pulkrábek, Jiří - Rektor, Ivan
PY - 2005
TI - The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial
JF - Parkinsonism and Related Disorders
VL - 11
IS - 8
SP - 509-512
EP - 509-512
PB - Elsevier
SN - 13538020
KW - Parkinson disease
KW - pergolid
KW - sexual dysfunction
N2 - Fourteen male patients suffering from Parkinson's disease, each of whom had been treated with L-DOPA, and in whom additional treatment with oral dopamine agonist (DA) was needed, were followed for a period of one year. Pergolide mesylate was given to each patient, and titrated to a total daily dose of 3 mg. All of the patients were taking L-DOPA. The assessments consisted of neurological examination, unified Parkinson's disease rating scale (UPDRS) III and IV subscales scoring, mini mental state examination (MMSE) scoring, the neuropsychological examination, biochemical and hematological examinations and a sexological examination during which the patients filled-in the international index of erectile function (IIEF) questionnaire. Pergolide mesylate significantly improved all sexual functions in younger male Parkinsonian patients who were still interested in sexual activities.
ER -
POHANKA, Michal, Petr KAŇOVSKÝ, Martin BAREŠ, Jiří PULKRÁBEK a Ivan REKTOR. The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial. Online. \textit{Parkinsonism and Related Disorders}. Oxford: Elsevier, 2005, roč.~11, č.~8, s.~509-512. ISSN~1353-8020. [citováno 2024-04-23]
|
